Evidence map›Paper›PMID 42601552›Full record

ArticleClinical journal of gastroenterology2026

Alpha-fetoprotein elevation in an asymptomatic young adult as a diagnostic clue to colorectal adenocarcinoma with enteroblastic differentiation.

Nobuyasu Ikai, Makoto Takenouchi, Takayuki Shimpoh, Hiyo Obikane

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nobuyasu IkaiDepartment of Diagnostic Pathology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Makoto TakenouchiDepartment of Surgery, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Takayuki ShimpohDepartment of Gastroenterology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Hiyo ObikaneDepartment of Diagnostic Pathology, Tokyo Metropolitan Police Hospital, Tokyo, Japan. obikane.hiyo@gmail.com.ORCID http://orcid.org/0000-0002-1400-6337

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal adenocarcinoma with enteroblastic differentiation (CAED) is a rare and aggressive histological subtype of colorectal adenocarcinoma characterized by the expression of enteroblastic markers, including alpha-fetoprotein (AFP), glypican-3, and spalt-like transcription factor 4 (SALL4). CAED typically affects older adults and is often diagnosed at an advanced stage. We report a rare case of AFP-producing CAED in a 29-year-old asymptomatic man whose markedly elevated serum AFP level served as a diagnostic clue. After elevated serum AFP was incidentally detected during a routine medical examination at a local clinic, markedly elevated serum AFP was confirmed at his initial visit to our hospital. Hepatocellular carcinoma and germ cell tumors were excluded by laboratory and imaging studies. Colonoscopy identified a transverse colon tumor, and the patient underwent curative resection. Histopathological examination demonstrated CAED with clear cytoplasm and positivity for AFP, SALL4, and glypican-3, confirming expression of all three enteroblastic markers. The pathological stage was pT3N2b, Stage IIIC. Serum AFP normalized after surgery, before the initiation of adjuvant chemotherapy, and the patient remains free of recurrence 12 months after surgery. This case highlights markedly elevated serum AFP as a potential diagnostic clue that may facilitate the early recognition of CAED, even in asymptomatic young adults.

Indexed as

Alpha-fetoproteinColorectal adenocarcinoma with enteroblastic differentiationEnteroblastic differentiationYoung adult

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.